Impact of diabetes in the Friedreich ataxia clinical outcome measures study.

about

Impact of diabetes in the Friedreich ataxia clinical outcome measures study.

Item

http://www.wikidata.org/entity/Q41509984

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Impact of diabetes in the Friedreich ataxia clinical outcome measures study.

@en

type

Item

label

Impact of diabetes in the Friedreich ataxia clinical outcome measures study.

@en

prefLabel

Impact of diabetes in the Friedreich ataxia clinical outcome measures study.

@en

P1476

Impact of diabetes in the Friedreich ataxia clinical outcome measures study.

@en

P2093

Ashley McCormick

http://www.w3.org/2001/XMLSchema#string

Chad Hoyle

http://www.w3.org/2001/XMLSchema#string

David R Lynch

http://www.w3.org/2001/XMLSchema#string

George Wilmot

http://www.w3.org/2001/XMLSchema#string

Grace Yoon

http://www.w3.org/2001/XMLSchema#string

Jennifer Farmer

http://www.w3.org/2001/XMLSchema#string

Katherine Matthews

http://www.w3.org/2001/XMLSchema#string

Martin Delatycki

http://www.w3.org/2001/XMLSchema#string

Sub H Subramony

http://www.w3.org/2001/XMLSchema#string

Susan Perlman

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase

Friedreich ataxia: an overview

Metformin-associated lactic acidosis: Current perspectives on causes and risk

PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease

The relationship between metformin therapy and the fasting plasma lactate in type 2 diabetes: The Fremantle Diabetes Study

Frataxin is essential for extramitochondrial Fe-S cluster proteins in mammalian tissues

2000 CDC Growth Charts for the United States: methods and development

Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design.

P304

622-631

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ACN3.439

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Shana McCormack

P577

2017-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28904984

http://www.w3.org/2001/XMLSchema#string

P932

5590524

http://www.w3.org/2001/XMLSchema#string